Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43,411,663
-
Total 13F shares
-
6,080,606
-
Share change
-
+1,578,714
-
Total reported value
-
$51,262,809
-
Price per share
-
$8.43
-
Number of holders
-
44
-
Value change
-
+$13,288,944
-
Number of buys
-
30
-
Number of sells
-
8
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q3 2019
As of 30 Sep 2019 Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) had 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 6,080,606 shares of stock of the company.
Largest 10 holders included Nantahala Capital Management, LLC, BlackRock Inc., Slate Path Capital LP, VANGUARD GROUP INC, 683 Capital Management, LLC, STATE STREET CORP, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, Nuveen Asset Management, LLC, and HSBC HOLDINGS PLC.
This table shows 44 institutional shareholders of the security as of 30 Sep 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.